JP2002510966A - 自動蛋白質デザインのための装置および方法 - Google Patents
自動蛋白質デザインのための装置および方法Info
- Publication number
- JP2002510966A JP2002510966A JP54410998A JP54410998A JP2002510966A JP 2002510966 A JP2002510966 A JP 2002510966A JP 54410998 A JP54410998 A JP 54410998A JP 54410998 A JP54410998 A JP 54410998A JP 2002510966 A JP2002510966 A JP 2002510966A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- sequence
- rotamers
- residues
- rotamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Wood Science & Technology (AREA)
- Theoretical Computer Science (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Evolutionary Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.プログラムの制御下でコンピューターによって実行される方法であって、 該コンピューターは該プログラムを保存するためのメモリーを含み、該方法は、 (A)可変残基位置を持つ蛋白質骨格構造を受領し; (B)該可変残基位置の各々について可能なロタマーの群を確立し、ここに、 少なくとも1つの可変残基位置は少なくとも2つの異なるアミノ酸側鎖からのロ タマーを有し;次いで、 (C)該ロタマーの各々と該蛋白質骨格構造の残りの全てまたは一部との相互 作用を解析して、最適化蛋白質配列のセットを生成させ、ここに、該分析工程は デッドエンド排除(DEE)計算を含む; 工程を含むことを特徴とする該方法。 2.プログラムの制御下でコンピューターによって実行される方法であって、 該コンピューターは該プログラムを保存するためのメモリーを含み、該方法は、 (A)可変残基位置を持つ蛋白質骨格構造を受領し; (B)各可変残基位置をコア、表面または境界残基に分類し、 (C)該可変残基位置の各々について可能なロタマーの群を確立し、ここに、 少なくとも1つの可変残基位置は少なくとも2つの異なるアミノ酸側鎖からのロ タマーを有し;次いで、 (D)該ロタマーの各々と該蛋白質骨格構造の残りの全てまたは一部との相互 作用を解析して、最適化蛋白質配列のセットを生成させる; 工程を含むことを特徴とする該方法。 3.該解析工程がDEE計算を含む請求項2記載の方法。 4.最適化蛋白質配列の該セットが全体最適蛋白質配列を含む請求項1または 2記載の方法。 5.該DEE計算がオリジナルのDEEおよびゴールドシュティン(Goldstei n)DEEよりなる群から選択される請求項1または3記載の方法。 6.該解析工程が少なくとも1つのスコアリング機能の使用を含む請求項1ま たは2記載の方法。 7.該スコアリング機能がファンデルワールスポテンシャルスコアリング機能 、水素結合ポテンシャルスコアリング機能、原子溶媒和スコアリング機能、静電 スコアリング機能および二次構造特性スコアリング機能よりなる群から選択され る請求項6記載の方法。 8.該解析工程が少なくとも2つのスコアリング機能を含む請求項6記載の方 法。 9.該解析工程が少なくとも3つのスコアリング機能を含む請求項6記載の方 法。 10.該解析工程が少なくとも4つのスコアリング機能を含む請求項6記載の 方法。 11.さらに、少なくとも1つの数の該セットをテストして、実験結果を生じ させることを含む請求項1または2記載の方法。 12.さらに、(D)該全体最適蛋白質配列からさらなる最適配列のランク付 けされたリストを生成させることを含む請求項4記載の方法。 13.該生成がモンテカルロサーチの使用を含む請求項12記載の方法。 14.該解析工程がモンテカルロ計算を含む請求項2記載の方法。 15.さらに、(E)該ランク付けリストからの該蛋白質配列のいくつかまた は全てをテストして、ポテンシャルエネルギーテスト結果を得ることを含む請求 項12記載の方法。 16.さらに、(F)該ポテンシャルエネルギーテスト結果および理論的ポテ ンシャルエネルギーデータの間の対応性を解析することを含む請求項15記載の 方法。 17.請求項1または2の方法によって生成した最適化蛋白質。 18.請求項17記載の蛋白質配列をコードする核酸配列。 19.請求項18記載の核酸を含む発現ベクトル。 20.請求項18記載の核酸を含む宿主細胞。 21.公知の蛋白質配列から少なくとも約5%異なり、公知の蛋白質配列より も少なくとも20%安定である配列を有する蛋白質。 22.蛋白質骨格モデルの残基位置についての潜在的ロタマーの群を修正する ための側鎖モジュール; 該ロタマーの各々と該蛋白質の残りの全てまたは一部との相互作用を解析して 最適化蛋白質配列のランキングモジュール; を含むコンピューターを指令して特異的に機能させるコンピューター解読可能な メモリー。 23.該ランキングモジュールがファンデルワールススコアリング機能成分を 含む請求項22記載のコンピューター解読可能メモリー。 24.該ランキングモジュールが原子溶媒和スコアリング機能成分を含む請求 項22記載のコンピューター解読可能メモリー。 25.該ランキングモジュールが水素結合スコアリング機能成分を含む請求項 22記載のコンピューター解読可能メモリー。 26.該ランキングモジュールが二次構造スコアリング機能成分を含む請求項 22記載のコンピューター解読可能メモリー。 27.さらに、ポテンシャルエネルギーテスト結果および理論的ポテンシャル エネルギーデータの間の対応性を評価するための接近可能モジュールを含む請求 項22記載のコンピューター解読可能メモリー。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4346497P | 1997-04-11 | 1997-04-11 | |
US60/043,464 | 1997-04-11 | ||
US5467897P | 1997-08-04 | 1997-08-04 | |
US60/054,678 | 1997-08-04 | ||
US6109797P | 1997-10-03 | 1997-10-03 | |
US60/061,097 | 1997-10-03 | ||
PCT/US1998/007254 WO1998047089A1 (en) | 1997-04-11 | 1998-04-10 | Apparatus and method for automated protein design |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002510966A true JP2002510966A (ja) | 2002-04-09 |
Family
ID=27366337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54410998A Ceased JP2002510966A (ja) | 1997-04-11 | 1998-04-10 | 自動蛋白質デザインのための装置および方法 |
Country Status (8)
Country | Link |
---|---|
US (11) | US6188965B1 (ja) |
EP (1) | EP0974111B1 (ja) |
JP (1) | JP2002510966A (ja) |
AU (1) | AU751331B2 (ja) |
CA (1) | CA2286262A1 (ja) |
DE (1) | DE69810603T2 (ja) |
DK (1) | DK0974111T3 (ja) |
WO (1) | WO1998047089A1 (ja) |
Families Citing this family (190)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060277017A1 (en) * | 1993-11-04 | 2006-12-07 | Sproch Norman K | Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling |
US7047171B1 (en) * | 1995-12-08 | 2006-05-16 | Sproch Norman K | Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling |
EP0974111B1 (en) * | 1997-04-11 | 2003-01-08 | California Institute Of Technology | Apparatus and method for automated protein design |
US20030049654A1 (en) * | 1998-10-16 | 2003-03-13 | Xencor | Protein design automation for protein libraries |
US20020048772A1 (en) * | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
US7315786B2 (en) * | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
CA2347214A1 (en) * | 1998-10-16 | 2000-04-27 | Klaus M. Fiebig | Protein design automation for protein libraries |
US6403312B1 (en) | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
US7208473B2 (en) | 1999-01-06 | 2007-04-24 | Xencor, Inc. | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
US6627186B1 (en) | 1999-01-06 | 2003-09-30 | Xencor | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
US6917882B2 (en) * | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
EP1151409A1 (en) * | 1999-01-18 | 2001-11-07 | Maxygen, Inc. | Methods of populating data stuctures for use in evolutionary simulations |
US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
EP1130093A1 (en) | 1999-01-19 | 2001-09-05 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US20070065838A1 (en) * | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6864359B1 (en) | 1999-02-11 | 2005-03-08 | Xencor | Structure-based screening techniques for drug discovery |
AU2880800A (en) * | 1999-02-11 | 2000-08-29 | Xencor, Inc. | Structure-based screening techniques for drug discovery |
JP3892167B2 (ja) * | 1999-03-19 | 2007-03-14 | 富士通株式会社 | 粒子集団の配置を生成する生成装置および方法 |
US6343257B1 (en) | 1999-04-23 | 2002-01-29 | Peptor Ltd. | Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library |
CA2372871A1 (en) * | 1999-05-12 | 2000-11-16 | Xencor, Inc. | Novel nucleic acids and proteins with growth hormone activity |
US6946265B1 (en) | 1999-05-12 | 2005-09-20 | Xencor, Inc. | Nucleic acids and proteins with growth hormone activity |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
US6682923B1 (en) | 1999-05-12 | 2004-01-27 | Xencor | Thermostable alkaliphilic xylanase |
JP2002543791A (ja) * | 1999-05-12 | 2002-12-24 | ゼンコー | 新規な熱安定性の親アルカリ性キシラナーゼ |
US6334099B1 (en) * | 1999-05-25 | 2001-12-25 | Digital Gene Technologies, Inc. | Methods for normalization of experimental data |
AU8037200A (en) * | 1999-09-01 | 2001-03-26 | California Institute Of Technology | Methods and compositions utilizing a branch and terminate algorithm for protein design |
US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US8229721B1 (en) | 1999-11-03 | 2012-07-24 | Lonza Biologics Plc | Apparatus and method for structure-based prediction of amino acid sequences |
ATE341793T1 (de) * | 1999-11-03 | 2006-10-15 | Algonomics N V | Verfahren zum generieren von informationen in zusammenhang mit der molekularstruktur eines biomoleküls |
EP1266337A2 (en) * | 1999-11-22 | 2002-12-18 | Yissum Research Development Company of the Hebrew University of Jerusalem | System and method for searching a combinatorial space |
JP3964087B2 (ja) * | 1999-12-24 | 2007-08-22 | 株式会社カネカ | 多重変異蛋白質アミノ酸配列の最適化解を算出する方法、装置、およびこの方法の処理を実行するプログラムを記憶する記憶媒体 |
US7462354B2 (en) * | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
EP1621617A1 (en) * | 2000-02-10 | 2006-02-01 | Xencor, Inc. | Protein design automation for protein libraries |
AU5168701A (en) * | 2000-02-10 | 2001-08-20 | Xencor | Protein design automation for protein libraries |
US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
US7244823B2 (en) * | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
US7662367B2 (en) * | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
US20070172449A1 (en) * | 2000-03-02 | 2007-07-26 | Xencor, Inc. | TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
EP1259616A2 (en) * | 2000-03-02 | 2002-11-27 | Xencor | Tnf-alpha variants for the treatment of tnf-alpha related disorders |
US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
US7101974B2 (en) * | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
US6983233B1 (en) | 2000-04-19 | 2006-01-03 | Symyx Technologies, Inc. | Combinatorial parameter space experiment design |
EP1314111A2 (en) * | 2000-05-24 | 2003-05-28 | California Institute Of Technology | Methods for protein design |
US6586207B2 (en) * | 2000-05-26 | 2003-07-01 | California Institute Of Technology | Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues |
DE10028875A1 (de) * | 2000-06-10 | 2001-12-20 | Hte Gmbh | Rechnergestützte Optimierung von Substanzbibliotheken |
AU2001282880A1 (en) * | 2000-07-07 | 2002-01-21 | California Institute Of Technology | Proteins with integrin-like activity |
WO2002005146A2 (en) * | 2000-07-10 | 2002-01-17 | Xencor, Inc. | Method for disigning protein libraries with altered immunogenicity |
WO2002014875A2 (en) * | 2000-08-16 | 2002-02-21 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Method and system for predicting amino acid sequence |
IL137886A0 (en) | 2000-08-16 | 2001-10-31 | Univ Ramot | A novel algorithm for de novo protein design |
WO2002038746A2 (en) * | 2000-11-10 | 2002-05-16 | Xencor | Novel thermostable alkaliphilic xylanase |
CA2431066C (en) * | 2000-12-15 | 2007-05-15 | Youqi Wang | Methods and apparatus for designing high-dimensional combinatorial experiments |
US7231328B2 (en) * | 2001-02-06 | 2007-06-12 | The Penn State Research Foundation | Apparatus and method for designing proteins and protein libraries |
US20030036854A1 (en) * | 2001-02-06 | 2003-02-20 | The Penn State Research Foundation | Apparatus and method for designing proteins and protein libraries |
US20020183937A1 (en) * | 2001-02-09 | 2002-12-05 | Stephen Mayo | Method for the generation of proteins with new enzymatic function |
US20030032065A1 (en) * | 2001-03-12 | 2003-02-13 | Vince Hilser | Ensemble-based strategy for the design of protein pharmaceuticals |
JP2005512161A (ja) * | 2001-03-12 | 2005-04-28 | ボード オブ レジェンツ,ザ ユニバーシティー オブ テキサス システム | ペプチドおよびタンパク質の立体配座アンサンブルの列挙およびリガンド親和性分析のためのコンピュータベースのストラテジー |
JP2005505250A (ja) * | 2001-05-04 | 2005-02-24 | ゼンコー | 核酸およびチオレドキシンレダクターゼ活性を有するタンパク質 |
US20030211511A1 (en) * | 2001-05-04 | 2003-11-13 | Briggs Steven P. | Nucleic acids and proteins with thioredoxin reductase activity |
US20030049680A1 (en) * | 2001-05-24 | 2003-03-13 | Gordon D. Benjamin | Methods and compositions utilizing hybrid exact rotamer optimization algorithms for protein design |
US7110525B1 (en) | 2001-06-25 | 2006-09-19 | Toby Heller | Agent training sensitive call routing system |
US20030022285A1 (en) * | 2001-07-10 | 2003-01-30 | Chirino Arthur J. | Protein design automation for designing protein libraries with altered immunogenicity |
EP1510959A3 (en) * | 2001-08-10 | 2006-07-26 | Xencor, Inc. | Protein design automation for protein libraries |
WO2003014325A2 (en) * | 2001-08-10 | 2003-02-20 | Xencor | Protein design automation for protein libraries |
CA2458919A1 (en) * | 2001-08-31 | 2003-03-13 | Optimum Power Technology, L.P. | Design optimization |
US6822073B2 (en) * | 2001-12-20 | 2004-11-23 | Kimberly-Clark Worldwide, Inc. | Modular peptide-based reagent |
US7381792B2 (en) * | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
WO2003073238A2 (en) * | 2002-02-27 | 2003-09-04 | California Institute Of Technology | Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
US20040110226A1 (en) * | 2002-03-01 | 2004-06-10 | Xencor | Antibody optimization |
US20070148171A1 (en) * | 2002-09-27 | 2007-06-28 | Xencor, Inc. | Optimized anti-CD30 antibodies |
US7662925B2 (en) | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
US8188231B2 (en) | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
US20080260731A1 (en) * | 2002-03-01 | 2008-10-23 | Bernett Matthew J | Optimized antibodies that target cd19 |
US20040132101A1 (en) * | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
US20080254027A1 (en) * | 2002-03-01 | 2008-10-16 | Bernett Matthew J | Optimized CD5 antibodies and methods of using the same |
US7317091B2 (en) * | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
JP4209334B2 (ja) * | 2002-03-26 | 2009-01-14 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | 3次元分子構造の最適モデルを構築する方法及びシステム |
AU2003220559A1 (en) * | 2002-03-26 | 2003-10-13 | Carnegie Mellon University | Methods and systems for molecular modeling |
WO2003087310A2 (en) * | 2002-04-04 | 2003-10-23 | California Institute Of Technology | Directed protein docking algorithm |
US7272545B2 (en) * | 2002-05-22 | 2007-09-18 | General Electric Company | Method and apparatus for designing and locating chemical structures |
JP2006507562A (ja) * | 2002-05-23 | 2006-03-02 | ザ ボード オブ レジェンツ−ザ ユニバーシティー オブ テキサス システム | アンサンブルベースの構造エネルギーを使用した一塩基多型(snps)の意義の予測 |
WO2004003683A2 (en) * | 2002-07-01 | 2004-01-08 | 3-Dimensional Pharmaceuticals, Inc. | Conformational sampling by self-organization |
DE10233047A1 (de) * | 2002-07-19 | 2004-02-26 | Amaxa Gmbh | Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein |
US20040082783A1 (en) * | 2002-08-06 | 2004-04-29 | Schafmeister Christian E. | Bis (amino acid) molecular scaffolds |
US20060235208A1 (en) * | 2002-09-27 | 2006-10-19 | Xencor, Inc. | Fc variants with optimized properties |
ES2562177T3 (es) | 2002-09-27 | 2016-03-02 | Xencor Inc. | Variantes de Fc optimizadas y métodos para su generación |
US20040175359A1 (en) * | 2002-11-12 | 2004-09-09 | Desjarlais John Rudolph | Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
US20050130892A1 (en) * | 2003-03-07 | 2005-06-16 | Xencor, Inc. | BAFF variants and methods thereof |
US7553930B2 (en) * | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
US20050221443A1 (en) * | 2003-01-06 | 2005-10-06 | Xencor, Inc. | Tumor necrosis factor super family agonists |
US20060014248A1 (en) * | 2003-01-06 | 2006-01-19 | Xencor, Inc. | TNF super family members with altered immunogenicity |
AU2004204942A1 (en) * | 2003-01-08 | 2004-07-29 | Xencor, Inc | Novel proteins with altered immunogenicity |
WO2004066168A1 (en) * | 2003-01-20 | 2004-08-05 | Cambridge University Technical Services Limited | Computational method and apparatus for predicting polypeptide aggregation or solubility |
WO2004065363A2 (en) * | 2003-01-21 | 2004-08-05 | The Trustees Of The University Of Pennsylvania | Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel kcsa |
US9818136B1 (en) | 2003-02-05 | 2017-11-14 | Steven M. Hoffberg | System and method for determining contingent relevance |
US20040176585A1 (en) * | 2003-02-27 | 2004-09-09 | Carter Richard J. | Method and system for determining optimal sequences |
US20090010920A1 (en) | 2003-03-03 | 2009-01-08 | Xencor, Inc. | Fc Variants Having Decreased Affinity for FcyRIIb |
US8084582B2 (en) | 2003-03-03 | 2011-12-27 | Xencor, Inc. | Optimized anti-CD20 monoclonal antibodies having Fc variants |
US8388955B2 (en) * | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
US20070275460A1 (en) * | 2003-03-03 | 2007-11-29 | Xencor.Inc. | Fc Variants With Optimized Fc Receptor Binding Properties |
US7610156B2 (en) * | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
AU2004227937B2 (en) * | 2003-03-31 | 2007-09-20 | Xencor, Inc | Methods for rational pegylation of proteins |
US9051373B2 (en) | 2003-05-02 | 2015-06-09 | Xencor, Inc. | Optimized Fc variants |
US20040229290A1 (en) * | 2003-05-07 | 2004-11-18 | Duke University | Protein design for receptor-ligand recognition and binding |
US20050064555A1 (en) * | 2003-07-09 | 2005-03-24 | Xencor, Inc. | Ciliary neurotrophic factor variants |
WO2005052839A2 (en) * | 2003-07-29 | 2005-06-09 | California Institute Of Technology | Systems and methods for predicting transmembrane domains in membrane proteins and mining the genome for recognizing g-protein coupled receptors |
WO2005017805A2 (en) * | 2003-08-13 | 2005-02-24 | California Institute Of Technology | Systems and methods for predicting the structure and function of multipass transmembrane proteins |
US7765175B2 (en) * | 2003-09-18 | 2010-07-27 | Optimum Power Technology, L.P. | Optimization expert system |
US20050065879A1 (en) * | 2003-09-18 | 2005-03-24 | Convergys Information Management Group, Inc. | System and method for web service billing |
US9714282B2 (en) | 2003-09-26 | 2017-07-25 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
US8101720B2 (en) | 2004-10-21 | 2012-01-24 | Xencor, Inc. | Immunoglobulin insertions, deletions and substitutions |
CA2542353A1 (en) | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
WO2005038596A2 (en) * | 2003-10-14 | 2005-04-28 | Verseon | Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion |
US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
GB0325817D0 (en) * | 2003-11-05 | 2003-12-10 | Univ Cambridge Tech | Method and apparatus for assessing polypeptide aggregation |
WO2005044087A2 (en) * | 2003-11-05 | 2005-05-19 | The Regents Of The University Of California | Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction |
WO2005047520A2 (en) * | 2003-11-07 | 2005-05-26 | Dna Software, Inc. | System and methods for three dimensional molecular structural analysis |
US7574306B1 (en) * | 2003-11-20 | 2009-08-11 | University Of Washington | Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations |
EP1697741A4 (en) | 2003-12-04 | 2008-02-13 | Xencor Inc | PROCESS FOR PRODUCING PROTEIN VARIANTS WITH INCREASED HOST STRUCTURE CONTENT AND COMPOSITIONS THEREOF |
US20060122783A1 (en) * | 2004-08-24 | 2006-06-08 | Ishikawa Muriel Y | System and method for heightening a humoral immune response |
US20060003412A1 (en) * | 2003-12-08 | 2006-01-05 | Xencor, Inc. | Protein engineering with analogous contact environments |
US20070249809A1 (en) * | 2003-12-08 | 2007-10-25 | Xencor, Inc. | Protein engineering with analogous contact environments |
US20050249723A1 (en) * | 2003-12-22 | 2005-11-10 | Xencor, Inc. | Fc polypeptides with novel Fc ligand binding sites |
WO2005092925A2 (en) * | 2004-03-24 | 2005-10-06 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
US20050260711A1 (en) * | 2004-03-30 | 2005-11-24 | Deepshikha Datta | Modulating pH-sensitive binding using non-natural amino acids |
WO2005109158A2 (en) * | 2004-05-05 | 2005-11-17 | Massachusetts Institute Of Technology | Methods and systems for generating peptides |
US20050287639A1 (en) | 2004-05-17 | 2005-12-29 | California Institute Of Technology | Methods of incorporating amino acid analogs into proteins |
WO2005113599A1 (en) * | 2004-05-21 | 2005-12-01 | Xencor, Inc. | C1q family member proteins with altered immunogenicity |
US20150010550A1 (en) | 2004-07-15 | 2015-01-08 | Xencor, Inc. | OPTIMIZED Fc VARIANTS |
US20060074225A1 (en) * | 2004-09-14 | 2006-04-06 | Xencor, Inc. | Monomeric immunoglobulin Fc domains |
US20060136139A1 (en) * | 2004-10-12 | 2006-06-22 | Elcock Adrian H | Rapid computational identification of targets |
US10755905B2 (en) * | 2004-10-28 | 2020-08-25 | Cerno Bioscience Llc | Qualitative and quantitative mass spectral analysis |
CN102746404B (zh) | 2004-11-12 | 2016-01-20 | 赞科股份有限公司 | 对FcRn的结合被改变的Fc变体 |
US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
US8367805B2 (en) * | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US20070135620A1 (en) * | 2004-11-12 | 2007-06-14 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
AU2006204791A1 (en) * | 2005-01-12 | 2006-07-20 | Xencor, Inc | Antibodies and Fc fusion proteins with altered immunogenicity |
WO2006094234A1 (en) * | 2005-03-03 | 2006-09-08 | Xencor, Inc. | Methods for the design of libraries of protein variants |
US20080207467A1 (en) * | 2005-03-03 | 2008-08-28 | Xencor, Inc. | Methods for the design of libraries of protein variants |
BRPI0614695A2 (pt) | 2005-07-29 | 2011-04-12 | Targeted Growth Inc | proteção de proteìna krp mutante negativa dominante de inibição de complexo ciclina-cdk ativo por krp do tipo silvestre |
WO2007030426A2 (en) * | 2005-09-07 | 2007-03-15 | Board Of Regents, The University Of Texas System | Methods of using and analyzing biological sequence data |
US20070072226A1 (en) * | 2005-09-27 | 2007-03-29 | Indiana University Research & Technology Corporation | Mining protein interaction networks |
EP1931709B1 (en) * | 2005-10-03 | 2016-12-07 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
CA2625998C (en) | 2005-10-06 | 2015-12-01 | Xencor, Inc. | Optimized anti-cd30 antibodies |
JP2009514535A (ja) * | 2005-11-03 | 2009-04-09 | レッドポイント バイオ コーポレイション | Trpm5イオンチャネルのためのハイスループットスクリーニングアッセイ |
WO2007061850A2 (en) * | 2005-11-17 | 2007-05-31 | Massachusetts Institute Of Technology | Methods and systems for generating and evaluating peptides |
JP5808882B2 (ja) | 2006-03-03 | 2015-11-10 | カリフォルニア インスティテュート オブ テクノロジー | 分子へのアミノ酸の部位特異的な組み込み |
US20070208411A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent with surface area gradient |
US20070254307A1 (en) * | 2006-04-28 | 2007-11-01 | Verseon | Method for Estimation of Location of Active Sites of Biopolymers Based on Virtual Library Screening |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
EP2581450B1 (en) | 2006-05-02 | 2018-08-15 | MedImmune Limited | Non-natural amino acid substituted polypeptides |
EP2031528A4 (en) * | 2006-05-26 | 2009-06-17 | Univ Kyoto | ESTIMATING A PROTEIN-COMPOUND INTERACTION AND RATIONAL DESIGN OF A LIBRARY OF COMPOUNDS BASED ON CHEMICAL GENOMIC INFORMATION |
US7674594B2 (en) * | 2006-07-27 | 2010-03-09 | Redpoint Bio Corporation | Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol |
AU2007285976B2 (en) | 2006-08-14 | 2011-08-18 | Xencor, Inc | Optimized antibodies that target CD19 |
CA2660795C (en) * | 2006-09-18 | 2014-11-18 | Xencor, Inc. | Optimized antibodies that target hm1.24 |
AU2008247815B2 (en) | 2007-05-02 | 2012-09-06 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
US7580304B2 (en) * | 2007-06-15 | 2009-08-25 | United Memories, Inc. | Multiple bus charge sharing |
CA2707840A1 (en) * | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
US7875452B2 (en) * | 2007-10-01 | 2011-01-25 | Redpoint Bio Corporation | Non-desensitizing mutant of the transient receptor potential TRPM5 ion channel |
MX338336B (es) | 2007-11-20 | 2016-04-07 | Ambrx Inc | Polipeptidos de insulina modificados y sus usos. |
PL2235059T3 (pl) | 2007-12-26 | 2015-08-31 | Xencor Inc | Warianty FC o zmodyfikowanym wiązaniu do FCRN |
WO2009149218A2 (en) * | 2008-06-03 | 2009-12-10 | Codon Devices, Inc. | Novel proteins and methods of designing and using same |
PT2318029T (pt) | 2008-07-23 | 2018-01-10 | Ambrx Inc | Polipéptidos de g-csf bovino modificados e suas utilizações |
WO2010080720A2 (en) | 2009-01-12 | 2010-07-15 | Nektar Therapeutics | Conjugates of a lysosomal enzyme moiety and a water soluble polymer |
EP2467398B1 (en) | 2009-08-20 | 2019-10-09 | Poseida Therapeutics, Inc. | Trpc4 inhibitors and uses thereof |
US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
US20120283171A1 (en) | 2009-12-21 | 2012-11-08 | Ambrx, Inc. | Modified bovine somatotropin polypeptides and their uses |
SG181769A1 (en) | 2009-12-21 | 2012-07-30 | Ambrx Inc | Modified porcine somatotropin polypeptides and their uses |
WO2011091078A2 (en) | 2010-01-19 | 2011-07-28 | Xencor, Inc. | Antibody fc variants with enhanced complement activity |
PL2605789T3 (pl) | 2010-08-17 | 2019-11-29 | Ambrx Inc | Zmodyfikowane polipeptydy relaksyny i ich zastosowania |
AR083006A1 (es) | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
EP3485889B1 (en) | 2011-12-16 | 2023-09-06 | Poseida Therapeutics, Inc. | Trpc4 modulators for use in the treatment or prevention of pain |
US20130252280A1 (en) * | 2012-03-07 | 2013-09-26 | Genformatic, Llc | Method and apparatus for identification of biomolecules |
WO2014144963A1 (en) | 2013-03-15 | 2014-09-18 | Alexandre Zanghellini | Automated method of computational enzyme identification and design |
WO2014201566A1 (en) * | 2013-06-21 | 2014-12-24 | Zymeworks Inc. | Systems and methods for physical parameter fitting on the basis of manual review |
US10381326B2 (en) | 2014-05-28 | 2019-08-13 | Invensas Corporation | Structure and method for integrated circuits packaging with increased density |
EP3436470A4 (en) | 2016-04-01 | 2019-11-20 | University of Washington | POLYPEPTIDES CAPABLE OF FORMING HOMO-OLIGOMERS HAVING SPECIFICITY MEDIATED BY MODULAR HYDROGEN BOND NETWORKS AND THEIR DESIGN |
SG11202005732XA (en) | 2017-12-19 | 2020-07-29 | Xencor Inc | Engineered il-2 fc fusion proteins |
US20190325986A1 (en) * | 2018-04-24 | 2019-10-24 | Samsung Electronics Co., Ltd. | Method and device for predicting amino acid substitutions at site of interest to generate enzyme variant optimized for biochemical reaction |
CA3111576A1 (en) | 2018-09-11 | 2020-03-19 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and their uses |
AU2019361206A1 (en) | 2018-10-19 | 2021-06-03 | Ambrx, Inc. | Interleukin-10 polypeptide conjugates, dimers thereof, and their uses |
AU2021233909A1 (en) | 2020-03-11 | 2022-09-29 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and methods of use thereof |
CN114495243B (zh) * | 2022-04-06 | 2022-07-05 | 第六镜科技(成都)有限公司 | 图像识别模型训练及图像识别方法、装置、电子设备 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939666A (en) * | 1987-09-02 | 1990-07-03 | Genex Corporation | Incremental macromolecule construction methods |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5265030A (en) * | 1990-04-24 | 1993-11-23 | Scripps Clinic And Research Foundation | System and method for determining three-dimensional structures of proteins |
US5241470A (en) * | 1992-01-21 | 1993-08-31 | The Board Of Trustees Of The Leland Stanford University | Prediction of protein side-chain conformation by packing optimization |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US5878373A (en) * | 1996-12-06 | 1999-03-02 | Regents Of The University Of California | System and method for determining three-dimensional structure of protein sequences |
GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
EP0974111B1 (en) * | 1997-04-11 | 2003-01-08 | California Institute Of Technology | Apparatus and method for automated protein design |
US7315786B2 (en) * | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
US20020048772A1 (en) * | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
US20030049654A1 (en) * | 1998-10-16 | 2003-03-13 | Xencor | Protein design automation for protein libraries |
CA2347214A1 (en) | 1998-10-16 | 2000-04-27 | Klaus M. Fiebig | Protein design automation for protein libraries |
US6403312B1 (en) * | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
JP2002543791A (ja) | 1999-05-12 | 2002-12-24 | ゼンコー | 新規な熱安定性の親アルカリ性キシラナーゼ |
AU5168701A (en) | 2000-02-10 | 2001-08-20 | Xencor | Protein design automation for protein libraries |
WO2003014325A2 (en) * | 2001-08-10 | 2003-02-20 | Xencor | Protein design automation for protein libraries |
-
1998
- 1998-04-10 EP EP98915478A patent/EP0974111B1/en not_active Expired - Lifetime
- 1998-04-10 US US09/058,459 patent/US6188965B1/en not_active Expired - Lifetime
- 1998-04-10 DE DE69810603T patent/DE69810603T2/de not_active Expired - Fee Related
- 1998-04-10 JP JP54410998A patent/JP2002510966A/ja not_active Ceased
- 1998-04-10 AU AU69654/98A patent/AU751331B2/en not_active Ceased
- 1998-04-10 CA CA002286262A patent/CA2286262A1/en not_active Abandoned
- 1998-04-10 WO PCT/US1998/007254 patent/WO1998047089A1/en active IP Right Grant
- 1998-04-10 DK DK98915478T patent/DK0974111T3/da active
- 1998-07-31 US US09/127,926 patent/US6269312B1/en not_active Expired - Lifetime
-
2000
- 2000-11-15 US US09/714,357 patent/US6708120B1/en not_active Expired - Lifetime
-
2001
- 2001-03-19 US US09/812,034 patent/US6950754B2/en not_active Expired - Lifetime
- 2001-04-04 US US09/827,960 patent/US6801861B2/en not_active Expired - Lifetime
- 2001-04-18 US US09/837,886 patent/US6804611B2/en not_active Expired - Lifetime
-
2002
- 2002-01-25 US US10/057,552 patent/US6792356B2/en not_active Expired - Lifetime
-
2004
- 2004-07-09 US US10/888,748 patent/US20050038610A1/en not_active Abandoned
-
2005
- 2005-07-28 US US11/193,654 patent/US20060019316A1/en not_active Abandoned
-
2006
- 2006-07-21 US US11/491,351 patent/US20070032961A1/en not_active Abandoned
- 2006-07-21 US US11/491,279 patent/US20060259247A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050038610A1 (en) | 2005-02-17 |
DE69810603D1 (de) | 2003-02-13 |
US6188965B1 (en) | 2001-02-13 |
US20070032961A1 (en) | 2007-02-08 |
US6269312B1 (en) | 2001-07-31 |
US20060259247A1 (en) | 2006-11-16 |
US6950754B2 (en) | 2005-09-27 |
US20010032052A1 (en) | 2001-10-18 |
EP0974111A1 (en) | 2000-01-26 |
WO1998047089A1 (en) | 1998-10-22 |
US20020106694A1 (en) | 2002-08-08 |
US20010039480A1 (en) | 2001-11-08 |
US6804611B2 (en) | 2004-10-12 |
EP0974111B1 (en) | 2003-01-08 |
US6801861B2 (en) | 2004-10-05 |
US6708120B1 (en) | 2004-03-16 |
AU6965498A (en) | 1998-11-11 |
US20020004706A1 (en) | 2002-01-10 |
US20060019316A1 (en) | 2006-01-26 |
US6792356B2 (en) | 2004-09-14 |
CA2286262A1 (en) | 1998-10-22 |
AU751331B2 (en) | 2002-08-15 |
DE69810603T2 (de) | 2003-11-13 |
DK0974111T3 (da) | 2003-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002510966A (ja) | 自動蛋白質デザインのための装置および方法 | |
EP1255209A2 (en) | Apparatus and method for automated protein design | |
Pallaghy et al. | Solution structure of contryphan-R, a naturally occurring disulfide-bridged octapeptide containing D-tryptophan: comparison with protein loops | |
Dalton et al. | Homology-modelling protein–ligand interactions: allowing for ligand-induced conformational change | |
Roe et al. | Folding cooperativity in a three-stranded β-sheet model | |
Durdagi et al. | Atomistic models for free energy evaluation of drug binding to membrane proteins | |
Worth et al. | Use of multiple molecular dynamics trajectories to study biomolecules in solution: the YTGP peptide | |
Polydorides et al. | Proteus and the design of ligand binding sites | |
Gong et al. | A holistic molecular docking approach for predicting protein-protein complex structure | |
Dwevedi | Protein folding: Examining the challenges from synthesis to folded form | |
Wang et al. | An atomic radii set and Generalized Born implicit solvation model trained using explicit water solvation free energy data | |
Roitberg | A molecular dynamics study of Fe2S2 putidaredoxin: multiple conformations of the C-terminal region | |
AU2002302138B2 (en) | Apparatus and method for automated protein design | |
AU2005211654B2 (en) | Apparatus and method for automated protein design | |
Karpusenka | Free Energy and Structure of Helix-forming Peptides: A theoretical investigation | |
Godwin | Binding Nemo: Adventures in Molecular Dynamics | |
Mokoena | Computational studies of the folding patterns of small and medium-size polypeptides | |
Li | Computational protein design: assessment and applications | |
Leis | Impact of Protein conformational Changes on Molecular Docking-Design of a Docking Approach including Receptor Flexibility | |
Stultz et al. | Fragment docking to proteins with the multi-copy simultaneous search methodology | |
Eisenman et al. | Structure and selectivity of Ca-binding sites in proteins: the 5-fold site in an icosahedral virus | |
Samsonov | Protein-protein interactions: impact of solvent and effects of fluorination | |
Falconi et al. | Molecular modeling and dynamics of copper proteins | |
Denison | A minimal model for the hydrophobic and hydrogen bonding effects on secondary and tertiary structure formation in proteins | |
Feng | New statistical potentials for improved protein structure prediction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070925 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071218 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080204 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20080325 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080526 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080603 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090707 |
|
AA92 | Notification that decision to refuse application was cancelled |
Free format text: JAPANESE INTERMEDIATE CODE: A971092 Effective date: 20090721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090804 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20091123 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100105 |